Cost-Outcome Description of PEG-IFN-α2b+RBV for Hepatitis C: Results Based on the Interferon Database-Reference-Cited by-同舟云学术

Cost-Outcome Description of PEG-IFN-α2b+RBV for Hepatitis C: Results Based on the Interferon Database

Published:2017 Issue:5 Volume:40 Page:594-597
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Akutagawa Maiko¹,Kawasaki Yohei¹²,Kawasaki Atsuko¹,Ide Kazuki¹²,Yamada Hiroshi¹,Masaki Naohiko³

Affiliation:

1. Department of Drug Evaluation & Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka

2. Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

3. Laboratory Testing Department, National Center for Global Health and Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/5/40_b16-00795/_pdf

Reference30 articles.

1. 1) Igarashi A. Economic evaluation in medicines. J. Natl. Inst. Public Heal., 62, 605–612 (2013).

2. 2) Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR, ISPOR Task Force on Good Research Practices--Modeling Studies. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health, 6, 9–17 (2003).

3. 3) Ministry of Health, Labour and Welfare. ‹http://www.mhlw.go.jp/file/05-Shingikai-12404000-Hokenkyoku-Iryouka/0000044418.pdf›, cited 2016-03-01.

4. 4) National Institute for Health and Clinical Excellence. “The guidelines manual. 7.2 Modelling approaches.”: ‹https://www.nice.org.uk/article/pmg6/chapter/7-assessing-cost-effectiveness#modelling-approaches›, cited 2016-03-01.

5. 5) “Registries for Evaluating Patient Outcomes: A User’s Guide: 3rd Edition - Research Report - Final | AHRQ Effective Health Care Program.”: ‹http://www.effectivehealthcare.ahrq.gov/ehc/products/420/1897/registries-guide-3rd-edition-vol-1-140430.pdf›, cited 2016-03-01.